Navigation Links
Inflamax Research announces the launch of its Mobile Environmental Exposure Chamber™ for conduct of Allergy & Asthma Trials
Date:1/18/2013

Toronto, ON (PRWEB) January 17, 2013

EEC technology is a clinical model that greatly enhances the sensitivity and specificity of pivotal clinical studies required for FDA drug registration. The Mobile EEC technology consists of transportable clinical facilities to perform controlled allergen exposure; allergic subjects sit in a validated environment room and are exposed to a controlled level of airborne allergen. Subjects exposed to allergen in this environment develop allergic symptoms in a known, predictable manner. The subjects are asked to record instantaneous symptoms on a diary card. The resulting data is far superior compared to traditional methods of evaluating anti-allergic drugs in development.

“Up to now EEC studies could only be performed in a single center setting within a fixed EEC site. This has limited the usefulness of this powerful technology to small, single center studies in one geographic location. There have been major challenges in recruiting specific types of subjects for these studies due to the limited volunteer pool locally, as well, the available volunteers have already been treated with immunomdulators which in some cases, excludes them from participation in future studies. With the Mobile EEC system, we can now go to geographic locations where the volunteers are. With the availability of Inflamax’s Mobile EEC system, we have noticed a significant decline in the interest in conducting fixed single site EEC studies from our clients in favor of the multi-center EEC approach.” says Dr Piyush Patel, CEO of Inflamax.

Inflamax has developed a network of Investigators in North America and Europe who will participate as sites to recruit subjects in diverse geographic locations for multi-center EEC trials. These investigator sites can recruit specific populations from their databases. With the availability of the Mobile EEC system, the potential pool of subjects is vastly increased.

“Ou
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Notre Dame to be part of $194 million university research center network
2. Researchers create method for more sensitive electrochemical sensors
3. Global Soil Treatment Market Forecast to Grow at a CAGR of 8.5% to 2017 in New Research Report at ReportsnReports.com
4. Global Healthcare Contract Research Outsourcing Market is expected to reach USD 65.03 billion by 2018: Transparency Market Research
5. Nanofiber Production Device Set to Accelerate Research into Nanofiber Applications in Medicine
6. CIS MDI (Methyl Diphenyl Diisocyanate) Market - New Industry Research Report Published by Transparency Market Research
7. Butanes Market - New Industry Research Report Published by Transparency Market Research
8. New research gives insight into graphene grain boundaries
9. Sustainable Valley Technology Group Provides Technology Innovation Grant To Help Researchers & Start-Ups With Funding, Business Support, Equipment & Facilities
10. Live Webinar on Protection of Phase 1 Research Volunteers
11. Rockingham County Economic Development Launches New Website to Market Research and Tech Park
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... In an article published and posted online today, senior ... the clinical aspects of diseases caused by 5 major ... "Clinical Management of Potential Bioterrorism-Related Conditions," was published and ... New England Journal of Medicine . ... Inglesby—review the clinical management of conditions resulting from exposure ...
(Date:3/4/2015)... 04, 2015 Research and Markets ... the "Global Biologics and Biosimilars Industry Report ... The Global Biologics and Biosimilars Industry ... on the current state of the biologics and ... basic overview of the industry including definitions, classifications, ...
(Date:3/4/2015)... March 4, 2015  BioClinica®, Inc., a ... provider, today announced that clinical trial professionals ... at its annual European User Conference in ... discuss the use of its eClinical technologies ... technologies include: the Microsoft Office-Smart OnPoint CTMS; ...
(Date:3/4/2015)... , March 4, 2015 ... innovative Entwicklungen für Diagnostik und Therapie, Strahlendosismanagement und ... Royal Philips (NYSE: PHG, ... Europäischen Röntgenkongress 2015 (ECR) bekannt, der vom ... stattfindet. An den Ständen Nr. 102 and ...
Breaking Biology Technology:Latest Clinical Information On Bioterrorism Threats 2Global Biologics and Biosimilars Industry Report 2015-2020 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 2Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 3Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 4Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 5Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 6
... Like most states, Wisconsin has long offered specialized ... it has lacked credit programs aimed at leveraging seed ... to change. Act 255, a tax-credit package that passed ... through an administrative rule process this summer, will provide ...
... Fiserv Imagesoft , a unit of Fiserv, ... services offering for its clients that have licensed ... ,The new multiple-option service is designed to ensure ... quickly, without interruption, after virtually any hardware, software ...
... of E. coli. Source: NAIAD Biodefense . ... on disease-causing pathogens, including ones that could be used ... will team with an information technology company, SRA ... library of data on these infectious agents and their ...
Cached Biology Technology:State investment incentives aimed at luring angels to start-up companies 2UW-Madison joins effort to build public pathogen bioinformatics database 2
(Date:2/24/2015)... Feb. 24, 2015 Research and Markets ... of the "Global 2D Gesture Recognition Market ... The analysts forecast the Global 2D Gesture ... 32.12% over the period 2014-2019 The ... sectors is one of the major trends in ...
(Date:2/13/2015)... , Feb. 13, 2015 ACT ... company that aims to transform cancer genomic information ... that the company has raised US$ 8 million in ... Based in Taipei, Taiwan , ... ACTDrug™, ACTOnco™. With the aim to implement next ...
(Date:2/10/2015)... 2015  Alere Inc. (NYSE: ALR), a global ... for the quarter ended December 31, 2014. ... of Alere said, "We made substantial progress in ... global leader in rapid diagnostics and delivering against ... divestiture in early January enabled us to substantially ...
Breaking Biology News(10 mins):Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2ACT Genomics Raises $8 Million in its First Private Funding Round 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34
... - Technology has transformed the way humans interact with the ... that will drive growth in marine and maritime sectors into ... will gather at the 3rd Marine Board Forum in Brussels ... has convened this flagship event on the understanding that technology ...
... Lugano-CH/Aurora-US-CO/Geneva-CH, 18 April 2012 -- New techniques for identifying ... screening, a nanotech ,nose, and a method to examine ... according to presentations at the 3rd European Lung Cancer ... lung cancer is vital to improve lung cancer survival ...
... genetic signature identified by Spanish researchers may provide doctors ... early stage lung cancer are at low or high ... 3rd European Lung Cancer Conference in Geneva. Their work ... Non-small cell lung cancer is a disease that ...
Cached Biology News:New technologies for a blue future 2Early detection techniques offer hope for improved outcomes in lung cancer patients 2Early detection techniques offer hope for improved outcomes in lung cancer patients 3Early detection techniques offer hope for improved outcomes in lung cancer patients 4Gene signature helps identify risk of relapse in lung cancer patients 2
Rabbit polyclonal to Testosterone 19 ( Abpromise for all tested applications). Antigen: Testosterone 19 CME HSA (Human)...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Goat polyclonal to Als2 ( Abpromise for all tested applications). entrezGeneID: 57679 SwissProtID: Q96Q42...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Biology Products: